Ortivus

Ortivus Gross Margin

The Gross Margin of Ortivus (ORTI B.ST) as of Nov 19, 2026 is 40.33 %. In the previous year, Gross Margin was 34.74 % — a change of 16.08% (higher).

Gross Margin

40.33 %

YoY

16.08%

Last updated:

Gross Margin of Ortivus is 2025 40.33 % . Gross Margin of Ortivus was 2024 34.74 % . It decreases by 16.08% higher compared to the previous year.

For Ortivus, the gross margin of 40.3% is down versus 50.8% a few years ago.

The Ortivus Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
42.24 SEK
Jan 1, 2019
41.27 SEK
Jan 1, 2020
36.21 SEK
Jan 1, 2021
50.78 SEK
Jan 1, 2022
46.62 SEK
Jan 1, 2023
36.68 SEK
Jan 1, 2024
34.74 SEK
Jan 1, 2025
40.33 SEK
The Ortivus Gross Margin history
YEARGross MarginYoY
40.33 %+16.08%
34.74 %-5.29%
36.68 %-21.32%
46.62 %-8.18%
50.78 %+40.24%
36.21 %-12.27%
41.27 %-2.29%
42.24 %-17.14%
50.98 %-22.06%
65.41 %-16.15%
78.00 %+15.36%
67.62 %+12,338.85%
0.54 %-2.55%
0.56 %+20.20%
0.46 %-13.32%
0.54 %-28.13%
0.74 %+2.21%
0.73 %+10.91%
0.66 %+7.82%
0.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ortivus stock

Gross Margin of Ortivus is 40.33 % in 2025.

Gross Margin of Ortivus changed from 34.74 % to 40.33 %, representing a 16.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Ortivus since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Ortivus with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ortivus

All Key Metrics — Ortivus